Carnerup MA - Search Results

1

Levels of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine from volunteers after experimental exposure to NMP in dry and humid air.

Carnerup MA, Spanne M, Jönsson BA. Carnerup MA, et al. Toxicol Lett. 2006 Apr 10;162(2-3):139-45. doi: 10.1016/j.toxlet.2005.09.035. Toxicol Lett. 2006. PMID: 16321482

2

Evaluation of exposure biomarkers from percutaneous absorption of N-methyl-2-pyrrolidone.

Akesson B, Carnerup MA, Jönsson BA. Akesson B, et al. Among authors: carnerup ma. Scand J Work Environ Health. 2004 Aug;30(4):306-12. doi: 10.5271/sjweh.799. Scand J Work Environ Health. 2004. PMID: 15458014 Free article.

3

Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats.

Carnerup MA, Saillenfait AM, Jönsson BA. Carnerup MA, et al. Food Chem Toxicol. 2005 Sep;43(9):1441-7. doi: 10.1016/j.fct.2005.04.007. Food Chem Toxicol. 2005. PMID: 15951091 Free article.

4

Determination of 5-hydroxy-N-methyl-2-pyrrolidone and 2-hydroxy-N-methylsuccinimide in human plasma and urine using liquid chromatography-electrospray tandem mass spectrometry.

Carnerup MA, Akesson B, Jönsson BA. Carnerup MA, et al. J Chromatogr B Biomed Sci Appl. 2001 Sep 15;761(1):107-13. doi: 10.1016/s0378-4347(01)00312-7. J Chromatogr B Biomed Sci Appl. 2001. PMID: 11585124

5

Characterization of a novel non-steroidal glucocorticoid receptor agonist optimized for topical treatment.

Eirefelt S, Stahlhut M, Svitacheva N, Carnerup MA, Da Rosa JMC, Ewald DA, Marstrand TT, Krogh-Madsen M, Dünstl G, Dack KN, Ollerstam A, Norsgaard H. Eirefelt S, et al. Among authors: carnerup ma. Sci Rep. 2022 Jan 27;12(1):1501. doi: 10.1038/s41598-022-05471-w. Sci Rep. 2022. PMID: 35087193 Free PMC article.

6

Topical 'dual-soft' glucocorticoid receptor agonist for dermatology.

Dack KN, Johnson PS, Henriksson K, Eirefelt S, Carnerup MA, Stahlhut M, Ollerstam AK. Dack KN, et al. Among authors: carnerup ma. Bioorg Med Chem Lett. 2020 Sep 1;30(17):127402. doi: 10.1016/j.bmcl.2020.127402. Epub 2020 Jul 13. Bioorg Med Chem Lett. 2020. PMID: 32738970

7

Fragment-Based Discovery of Pyrazolopyridones as JAK1 Inhibitors with Excellent Subtype Selectivity.

Hansen BB, Jepsen TH, Larsen M, Sindet R, Vifian T, Burhardt MN, Larsen J, Seitzberg JG, Carnerup MA, Jerre A, Mølck C, Lovato P, Rai S, Nasipireddy VR, Ritzén A. Hansen BB, et al. Among authors: carnerup ma. J Med Chem. 2020 Jul 9;63(13):7008-7032. doi: 10.1021/acs.jmedchem.0c00359. Epub 2020 Jun 8. J Med Chem. 2020. PMID: 32462873

8

Fragment-Based Discovery of 6-Arylindazole JAK Inhibitors.

Ritzén A, Sørensen MD, Dack KN, Greve DR, Jerre A, Carnerup MA, Rytved KA, Bagger-Bahnsen J. Ritzén A, et al. Among authors: carnerup ma. ACS Med Chem Lett. 2016 Apr 14;7(6):641-6. doi: 10.1021/acsmedchemlett.6b00087. eCollection 2016 Jun 9. ACS Med Chem Lett. 2016. PMID: 27326341 Free PMC article.

9

Correlating the metabolic stability of psychedelic 5-HT₂A agonists with anecdotal reports of human oral bioavailability.

Leth-Petersen S, Bundgaard C, Hansen M, Carnerup MA, Kehler J, Kristensen JL. Leth-Petersen S, et al. Among authors: carnerup ma. Neurochem Res. 2014 Oct;39(10):2018-23. doi: 10.1007/s11064-014-1253-y. Epub 2014 Feb 12. Neurochem Res. 2014. PMID: 24519542

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9 results

Search Page

Filters